Pennsylvania State University College of Medicine, known simply as Penn State College of Medicine is the medical school of Penn State.

During the past decade, Pennsylvania State University conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 16 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pennsylvania State University" #1 sponsor was "Shire" with 5 trials, followed by "Yale University" with 3 trials sponsored, "CSL Behring" with 2 trials sponsored, "Enterin Inc." with 2 trials sponsored and "Massachusetts General Hospital" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pennsylvania State University" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator, "Penn State University" with 4 trials as a collaborator, "Augusta University" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator and "University of California, San Francisco" with 3 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Pennsylvania State University" are "Hereditary Angioedema" (7 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "Constipation" (2 trials), "Parkinson Disease" (2 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Pennsylvania State University" in a lesser frequency.

Most popular intervention types in "Pennsylvania State University" are "Drug" (24 trials), "Biological" (9 trials), "Other" (7 trials), "Device" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "C1 esterase inhibitor [human] (C1INH-nf)" (4 trials), "Active Investigational Treatment ENT-01" (2 trials), "Prednisone" (2 trials) and "25% human albumin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pennsylvania State University" are 37 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pennsylvania State University". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Pennsylvania State University, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Pennsylvania State University, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".